The cellular neurobiology of depression
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Major depressive disorders, long considered to be of neurochemical origin, have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways may hold promise as new therapeutics for depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity that putatively mediates depressive symptoms (Drevets et al, 2002a), or by enhancing the expression of neurotrophic factors that protect medial network function from the effects of repeated stress (Manji et al, 2001).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Manji et al, 2001
In the citing paper
“Somatic antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity which putatively mediates depressive symptoms (Drevets et al. 2002a) and the expression of neurotrophic/neuroprotective factors that preserve the function of the MPFC (Manji et al. 2001).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Manji et al. 2001
In the citing paper
“Depression is often associated with elevated HPA axis activity and increased levels of glucocorticoids, as well as disruption of negative feedback mechanisms21–23.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [22]
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“However, the demonstration that neurogenesis occurs in the adult human brain into senescenc”
BackgroundThe Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332 · cited 1×
“Modest changes in this signaling cascade or in the levels of the Bcl-2 family of proteins (potentially due to genetic, illness or insult-related factors) could therefore profoundly affect cellular viabilit”
BackgroundGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“It is thus not altogether surprising that the Global Burden of Disease Study has identified MDDs among the leading causes of disability worldwide, and as illnesses likely to represent an increasingly greater health, societal and economic problem in the coming year”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Current research is examining the potential efficacy of antagonists of corticotropin-releasing factor (CRF), antiglucocorticoids and direct and indirect glutamate antagonist”
BackgroundSelf-citationChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“These studies demonstrate that chronic administration of different classes of antidepressants increases the proliferation and survival of new neuron”
BackgroundPsychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Moreover, lithium also inhibits the activity of glycogen synthase kinase 3β (GSK-3β”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · cited 1×
“have demonstrated that an important pathway involved in cell survival and plasticity, the cAMP–CREB cascade, is up-regulated by antidepressant treatmen”
BackgroundTHE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 1×
“Thus, although MDDs undoubtedly have a strong genetic basis, severe stressors have been associated with a substantial increase in risk for the onset of MDDs in susceptible individuals ( Table 3”
Background
Research works printed but not linked: 4
- Garlow, S.J., Musselman, D.L. & Nemeroff C.B. The Neurochemistry of Mood Disorders clinical studies. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 348–364 (Oxford Press, New York, 1999).
- Drevets, W.C., Gadde, K. & Krishnan, R. Neuroimaging studies of depression. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 394–418 (Oxford Press, New York, 1999).
- LeDoux, J.E. Emotion. in Handbook of Physiology—The Nervous System, Vol. V. (eds. Mills, J., Mountcastle, V.B., Plum, F. & Geiger, S.R.) 373–417 (Williams & Wilkins, Baltimore, 1987).
- Manji, H.K. et al. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. in Bipolar Medications: Mechanisms of Action. (eds. Manji, H.K., Bowden, C.L. & Belmaker, R.H.) 129–177 (American Psychiatric Press, Washington, DC, 2000).
Cited by
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
“…it is now generally viewed as a systems-level disorder affecting integrated pathways linking select cortical, subcortical, and limbic sites and their related neurotransmitter and molecular mediators (Manji et al., 2001; Mayberg, 1997; Nemeroff 2002; Nestler et al., 2002; Vaidya and Duman, 2001).”
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
Self-citationBelmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
“[5-7].”
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
“Similarly, antidepressants provide important relief in many individuals but their mechanisms of action are not completely understoo”
BackgroundSynaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Self-citationNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579
“In MDD, both OFC and ACC have shown a variety of alterations in gross morphology, neuronal structure, function, connectivity and neurochemistry (Botteron et al., 2002; Caetano et al., 2006; Chana et al., 2003; Coryell et al., 2005; Cotter et al., 2001; Drevets et al., 2002; Fitzgerald et al., 2008; Hastings et al., 20…”
BackgroundGold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
“In an important hypothesis by Nestler's group, and in the excellent work of Manji et al , abnormalities in growth factors and in other intracellular transduction mediators may play a highly significant role in the neurodegeneration in depressed patients”
MethodIntermediate phenotypes and genetic mechanisms of psychiatric disorders
Meyer-Lindenberg, A., & Weinberger, D. R. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1993 · Cited by 1,216
Adult hippocampal neurogenesis in depression
Sahay, A., & Hen, R. (2007) · Nature Neuroscience · doi:10.1038/nn1969 · Cited by 1,206
“The heterogeneity of depression implies that multiple neural substrates and mechanisms contribute to its etiolog”
BackgroundDiscovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
“The prominent cognitive deficits and brain volumetric changes in depression give additional weight to the contention that severe mood disorders arise, at least in part, from impairments of cellular plasticity and resilience (Manji et al, 2001; Manji and Duman, 2001).”
BackgroundSelf-citationThe subgenual anterior cingulate cortex in mood disorders
Drevets, W. C., Savitz, J., & Trimble, M. (2008) · CNS Spectrums · doi:10.1017/s1092852900013754 · Cited by 1,109
Self-citationCzéh, B., Michaelis, T., Watanabe, T., Frahm, J., de Biurrun, G., van Kampen, M., Bartolomucci, A., & Fuchs, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211427898 · Cited by 1,091
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Self-citationThe genetics of depression: A review
Levinson, D. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.024 · Cited by 855
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
“Antidepressant drugs acutely facilitate signaling of serotonin or norepinephrine by inhibiting their reuptake to presynaptic terminals (tricyclic antidepressants, such as imipramine) or by inhibiting their catabolism (monoamine oxidase inhibitors), or binding to serotonin autoreceptors (for review, see Duman et al., 1…”
BackgroundResultInfluentialMajor Depression Following Traumatic Brain Injury
Jorge, R. E., Robinson, R. G., Moser, D., Tateno, A., Crespo-Facorro, B., & Arndt, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.42 · Cited by 737
“Brain atrophic changes can be observed among patients with chronic mood disorders.(30,66,67) We analyzed the effect of a history of anxiety or depressive disorders on frontal lobe volumetric measures.”
BackgroundLopresti, A. L., Hood, S. D., & Drummond, P. D. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.014 · Cited by 663
Kreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., Maier, S. F., & Yirmiya, R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.155 · Cited by 663
Zhou, L., & Zhu, D.-Y. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.03.001 · Cited by 663
“Major depression is a chronic, recurring and potentially life threatening mental illness and will be the primary cause of disability in the world by the year 2020 estimated by the World Health Organization [107].”
TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment
Li, Y., Luikart, B. W., Birnbaum, S., Chen, J., Kwon, C.-H., Kernie, S. G., Bassel-Duby, R., & Parada, L. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.023 · Cited by 634
“Despite much excitement generated by recent advances in the knowledge of brain development and function, the mechanisms underlying the pathogenesis of depression, as well as its amelioration by antidepressant (AD) treatment, remain poorly understood (Manji et al., 2001; Nestler et al., 2002).”
BackgroundAntidepressant effect of optogenetic stimulation of the medial prefrontal cortex
Covington, H. E., Lobo, M. K., Maze, I., Vialou, V., Hyman, J. M., Zaman, S., LaPlant, Q., Mouzon, E., Ghose, S., Tamminga, C. A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1731-10.2010 · Cited by 621
“Altered functional activity within the medial and anterior regions of the prefrontal cortex is thought to be important for mediating key symptoms of depression (Manji et al., 2001; Keedwell et al., 2005; Krishnan and Nestler, 2008).”
BackgroundDepression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 612
Epilepsy and brain inflammation
Vezzani, A., Aronica, E., Mazarati, A., & Pittman, Q. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.033 · Cited by 603
“According to the serotonergic hypothesis, depression evolves as a result of the diminished output of serotonin from raphe nucleus into afferent projections, such as to the neocortex and the hippocampus (Manji et al., 2001).”
Pathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593
“Since then, multiple groups have investigated neuroanatomical and cellular alterations in the brain of depressed patients and suicide subjects (for reviews, see (Manji et al., 2001, Hercher et al., 2009, Russo and Nestler, 2013)).”
BackgroundThe Effects of Psychological Stress on Depression
Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1304150831150507 · Cited by 589
“Redundant GCs may also reduce the volume of hippocampus [42] thus affecting the function of brain areas related to emotion and reward circuitry.”
BackgroundDrevets, W. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00102-5 · Cited by 581
Self-citationAlterations in 5-HT 1B Receptor Function by p11 in Depression-Like States
Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., Yacoubi, M. E., Vaugeois, J.-M., Nomikos, G. G., & Greengard, P. (2006) · Science · doi:10.1126/science.1117571 · Cited by 572
Castrén, E. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1629 · Cited by 563
Preclinical models: status of basic research in depression
Nestler, E. J., Gould, E., & Manji, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01405-1 · Cited by 558
Self-citationLorenzetti, V., Allen, N. B., Fornito, A., & Yücel, M. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.021 · Cited by 553
Neuroimaging Abnormalities in the Amygdala in Mood Disorders
DREVETS, W. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07098.x · Cited by 544
Self-citationEdaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway
Dang, R., Wang, M., Li, X., Wang, H., Liu, L., Wu, Q., Zhao, J., Ji, P., Zhong, L., Licinio, J., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02400-6 · Cited by 520
“MDD was initially speculated to be a disease derived from neuronal dysfunction [49].”
BackgroundRole of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537
“Based on this adaptive plasticity model, research has focused on the molecular and cellular adaptations to chronic antidepressant administration to identify the critical changes that underlie treatment response (Duman et al., 2001b; Manji et al., 2001; Nestler et al., 2002).”
MethodAntidepressants and neuroplasticity
D'Sa, C., & Duman, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01203.x · Cited by 513
Barrot, M., Olivier, J. D. A., Perrotti, L. I., DiLeone, R. J., Berton, O., Eisch, A. J., Impey, S., Storm, D. R., Neve, R. L., Yin, J. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172091899 · Cited by 508
Sex differences in anxiety and depression: Role of testosterone
McHenry, J., Carrier, N., Hull, E., & Kabbaj, M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.09.001 · Cited by 501
“Recently proposed theories implicate signaling pathways related to synaptic plasticity as critical to the molecular mechanisms of antidepressants, with particular focus on the ERK pathway regarding emotional responses (Malberg et al., 2000, Manji et al., 2001, Einat et al., 2003, Qi et al., 2008).”
BackgroundMonteggia, L. M., Luikart, B., Barrot, M., Theobold, D., Malkovska, I., Nef, S., Parada, L. F., & Nestler, E. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.021 · Cited by 502
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., A. Gray, N., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 505
“Bcl-2 is now recognized as a major neuroprotective protein, because bcl-2 overexpression protects neurons against diverse insults, including ischemia, 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP), -amyloid, free radicals, excessive glutamate, and growth factor deprivation (Manji et al 2001b).”
BackgroundInfluentialSelf-citationStahl, S. M., Pradko, J., Haight, B. R., Modell, J. G., Rockett, C. B., & Learned-Coughlin, S. (2004) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v06n0403 · Cited by 495
“cause depression and modulate responses to antidepressants.(14,16,19) Several observations support an “upstream””
BackgroundAntidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jones, R. M., Portoghese, P. S., & Carlezon, W. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046433 · Cited by 485
“…recent research has become progressively focused upon the intracellular mechanisms of depression and antidepressant treatments (Duman, 2002; Nestler et al., 2002; Manji et al., 2001), with the goal of developing novel therapeutics that act faster, are more efficacious, and have fewer side effects.”
The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., Manji, H. K., & Chen, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07311.2003 · Cited by 481
“In addition to hippocampus and prefrontal cortex, clinical and postmortem studies also reveal abnormalities in other brain regions of patients with mood disorders ( Manji et al., 2001 ).”
BackgroundInfluentialSelf-citationMcMahon, F. J., Buervenich, S., Charney, D., Lipsky, R., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Papanicolaou, G. J., Laje, G., Fava, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503820 · Cited by 474
“Finally, a growing body of work suggests that antidepressants bring about their delayed therapeutic effects by the induction of neuronal plasticity mediated by increased expression of brain-derived neurotrophic factor (BDNF).(47,51,52) In this context, it is noteworthy that 5-HT2A antagonists block stress-induced down…”
BackgroundSelf-citationThe neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Rogawski, M. A., & Löscher, W. (2004) · Nature Medicine · doi:10.1038/nm1074 · Cited by 456
“It has been proposed that lithium and valproate promote neuronal survival and exert their antimanic effects through diverse effects on cell signalin”
Cytokines as mediators of depression: what can we learn from animal studies?
Dunn, A. J., Swiergiel, A. H., & Beaurepaire, R. D. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.023 · Cited by 459
“Antidepressants are presumed to work by normalizing a defect in brain serotonergic transmission through plastic changes or neurotrophic effects (Manji et al., 2001).”
BackgroundDrevets, W. C., Price, J. L., Bardgett, M. E., Reich, T., Todd, R. D., & Raichle, M. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00687-6 · Cited by 457
Self-citationStructural Plasticity and Hippocampal Function
Leuner, B., & Gould, E. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100359 · Cited by 455
“…of these is beyond the scope of this review, adult neurogenesis and other forms of structural plasticity have been implicated in addiction, schizophrenia, Alzheimer’s, and epilepsy (reviewed in Burke & Barnes 2006, Eisch et al. 2008, Manji et al. 2001, Russo et al. 2009, Swann et al. 2000).”
BackgroundTsankova, N. M., Kumar, A., & Nestler, E. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0589-04.2004 · Cited by 447
“…we examined how acute or chronic electroconvulsive seizures (ECS) alter these histone modifications in the hippocampus , a brain region implicated in the pathophysiology of depression in humans and in models of depression in animals (Duman et al., 1997; Manji et al., 2001; Nestler et al., 2002).”
BackgroundMitochondrial Dysfunction and Psychiatric Disorders
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & Streck, E. L. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9865-8 · Cited by 442
Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434
“…based on recent clinical and preclinical findings, which suggest that depressive disorders may be associated with an impairment of structural plasticity and cellular resilience, and that antidepressant medications may correct this dysfunction (Manji and Duman, 2001; Manji et al, 2000, 2001, 2003).”
BackgroundDevelopment and natural history of mood disorders
Costello, E. J., Pine, D. S., Hammen, C., March, J. S., Plotsky, P. M., Weissman, M. M., Biederman, J., Goldsmith, H. H., Kaufman, J., Lewinsohn, P. M., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01372-0 · Cited by 430
“Adversity during critical periods of prenatal or postnatal brain development seems to induce plastic changes, leading to permanent alterations in perceptions of, and responsiveness to, environmental events (Manji et al 2001).”
BackgroundCharney, D. S., & Manji, H. K. (2004) · Science's STKE · doi:10.1126/stke.2252004re5 · Cited by 429
Self-citationUnderstanding the Complex of Suicide in Depression: from Research to Clinics
Orsolini, L., Latini, R., Pompili, M., Serafini, G., Volpe, U., Vellante, F., Fornaro, M., Valchera, A., Tomasetti, C., Fraticelli, S., et al. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0171 · Cited by 406
Czéh, B., & Lucassen, P. J. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0728-0 · Cited by 419
“Contemporary theories place emphasis on the intracellular and structural changes, and suggest that disturbed neuroplasticity, including impaired adult hippocampal neurogenesis, might be implicated in the biological basis of major depression [9, 24, 66].”
BackgroundOrbitofrontal cortex function and structure in depression
DREVETS, W. C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1401.029 · Cited by 417
Self-citationPryce, C. R., Rüedi-Bettschen, D., Dettling, A. C., Weston, A., Russig, H., Ferger, B., & Feldon, J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.011 · Cited by 414
Neural and behavioral substrates of mood and mood regulation
Davidson, R. J., Lewis, D. A., Alloy, L. B., Amaral, D. G., Bush, G., Cohen, J. D., Drevets, W. C., Farah, M. J., Kagan, J., McClelland, J. L., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01458-0 · Cited by 411
Self-citationInflammation and depression: a causal or coincidental link to the pathophysiology?
Leonard, B. E. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.69 · Cited by 409
“More recently, attention has been directed to the role of neuropeptides, such as corticotropinreleasing factor and BDNF (38,86).”
BackgroundInfluentialGlutamate and Depression: Clinical and Preclinical Studies
PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408
Serotonin-1A receptor imaging in recurrent depression: replication and literature review
Drevets, W. C., Thase, M. E., Moses-Kolko, E. L., Price, J., Frank, E., Kupfer, D. J., & Mathis, C. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.06.008 · Cited by 399
“[65] Bcl-2 exerts both neuroprotective and neurotrophic effects in the mammalian CNS.[65] Finally, the elevation in 5-HT1AR binding could reflect enhancement of 5-HT1AR promoter activity, since high affinity AP-1 sites exist in the 5-HT1AR promoter and both lithium and divalproex robustly increase AP-1 DNA binding act…”
BackgroundSelf-citationCzéh, B., Müller-Keuker, J. I. H., Rygula, R., Abumaria, N., Hiemke, C., Domenici, E., & Fuchs, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301275 · Cited by 362
“Thus, these findings contributed to the formulation of a novel concept that structural alterations including suppressed dentate neurogenesis may contribute to the pathogenesis of depression (Manji et al, 2001; Duman, 2004).”
BackgroundFernandes, B. S., Gama, C. S., Maria Ceresér, K., Yatham, L. N., Fries, G. R., Colpo, G., de Lucena, D., Kunz, M., Gomes, F. A., & Kapczinski, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.002 · Cited by 389
Sequeira, A., Mamdani, F., Ernst, C., Vawter, M. P., Bunney, W. E., Lebel, V., Rehal, S., Klempan, T., Gratton, A., Benkelfat, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006585 · Cited by 388
“In addition, several studies have also investigated the role of signal transduction and other molecular systems [24–27].”
Kodama, M., Fujioka, T., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.008 · Cited by 387
Emerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
“The functional and morphometric findings in mood disorders have been extensively reviewed elsewhere (Drevets, 2000; Manji et al, 2001; Manji et al, 2000; Rajkowska, 2002).”
BackgroundSelf-citationNeurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
Yasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002099 · Cited by 358
Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments
Coyle, J. T., & Duman, R. S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00195-8 · Cited by 360
Chronic Unpredictable Stress Decreases Cell Proliferation in the Cerebral Cortex of the Adult Rat
Banasr, M., Valentine, G. W., Li, X.-Y., Gourley, S. L., Taylor, J. R., & Duman, R. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.006 · Cited by 342
Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies
Selvaraj, S., Arnone, D., Job, D., Stanfield, A., Farrow, T. F., Nugent, A. C., Scherk, H., Gruber, O., Chen, X., Sachdev, P. S., et al. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01000.x · Cited by 341
“Grey matter increase has been demonstrated following pharmacological treatment, such as lithium and mood stabilizers, in animal studies in the hippocampal sub regions by acting on post synaptic transduction pathways (62) and on N-acetyl aspartate, a putative marker for neuronal viability, in clinical samples (63).”
BackgroundTremblay, L. K., Naranjo, C. A., Graham, S. J., Herrmann, N., Mayberg, H. S., Hevenor, S., & Busto, U. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1228 · Cited by 340
“( 3 ) There was a statistically significant predrug difference between the MDD subjects and the controls but no postdrug difference.”
BackgroundA Role for MAP Kinase Signaling in Behavioral Models of Depression and Antidepressant Treatment
Duman, C. H., Schlesinger, L., Kodama, M., Russell, D. S., & Duman, R. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.047 · Cited by 341
Ciranna, L. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359540 · Cited by 336
“It is well known that psychiatric disorders such as depression and schizophrenia, causing emotional and cognitive disorders, are related to an alteration of the serotonin system [32, 113, 153, 178]; in these pathologies, some responsibility might be attributed to a disruption of 5HT-mediated control over glutamate- an…”
BackgroundANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
“…as well as alterations of growth factors (e.g., brain-derived neurotrophic factor; BDNF) (Duman and Monteggia, 2006; Duman et al., 2000, 2001; Manji et al., 2001) and cytokines that are more typically considered as immune system signaling molecules (e.g., interleukin-1, -2 and -6,…”
Song, L., Che, W., Min-wei, W., Murakami, Y., & Matsumoto, K. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.01.004 · Cited by 332
Hayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J., Sporn, J., Denicoff, K. K., Luckenbaugh, D., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 324
Self-citationThe neuropathology of primary mood disorder
Harrison, P. J. (2002) · Brain · doi:10.1093/brain/awf149 · Cited by 322
“…cytoarchitectural differences which will have consequences for the activity and plasticity of the affected neural circuits (Duman et al., 2000; Manji et al., 2001), and it is parsimonious to link these with the evidence for functional abnormalities referable to the same areas and circuits.”
BackgroundIssler, O., Haramati, S., Paul, E. D., Maeno, H., Navon, I., Zwang, R., Gil, S., Mayberg, H. S., Dunlop, B. W., Menke, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.042 · Cited by 318
“…such as major depression are among the most common health problems worldwide, affecting approximately 10% of the population (Berton and Nestler, 2006; Manji et al., 2001) and are associated with a large global burden of disease, according to the World Health Organization (Ustün et al., 2004).”
BackgroundRoceri, M., Cirulli, F., Pessina, C., Peretto, P., Racagni, G., & Riva, M. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.011 · Cited by 317
Heine, V. M., Maslam, S., Zareno, J., Joëls, M., & Lucassen, P. J. (2004) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.03100.x · Cited by 317
Wu, X., Chen, P. S., Dallas, S., Wilson, B., Block, M. L., Wang, C.-C., Kinyamu, H., Lu, N., Gao, X., Leng, Y., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009024 · Cited by 315
“Notably, post-mortem and brain-imaging studies in patients with unipolar or bipolar disorder reveal a loss of brain grey-matter volume and decrease in the cellular density, particularly glia, in discrete brain regions (Manji et al., 2001).”
BackgroundNewton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10883.2002 · Cited by 313
Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies
Murrough, J. W., Iacoviello, B., Neumeister, A., Charney, D. S., & Iosifescu, D. V. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.06.006 · Cited by 307
Self-citationWalter, M., Henning, A., Grimm, S., Schulte, R. F., Beck, J., Dydak, U., Schnepf, B., Boeker, H., Boesiger, P., & Northoff, G. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.39 · Cited by 306
Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305
“PLCc1 Pathway Signal transduction pathways activated by chronic antidepressant treatments have been intensively investigated (Duman et al, 1997; Manji et al, 2001; Coyle and Duman, 2003), but less is known about the pathways that are activated acutely by antidepressants.”
Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303
“…and clinical evidence suggested involvement of BDNF in both the pathophysiology of affective disorders and the mechanism of action of antidepressant drugs (Duman et al., 1999; Chen et al., 2001b; Manji et al., 2001, 2003; Neves-Pereira et al., 2002; Sklar et al., 2002; Egan et al., 2003).”
BackgroundCytokines, stress and depressive illness: Brain-immune interactions.
Anisman, H., & Merali, Z. (2003) · Annals of Medicine · doi:10.1080/07853890310004075 · Cited by 302
A Visual Circuit Related to Habenula Underlies the Antidepressive Effects of Light Therapy
Huang, L., Xi, Y., Peng, Y., Yang, Y., Huang, X., Fu, Y., Tao, Q., Xiao, J., Yuan, T., An, K., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.037 · Cited by 300
Genetics Factors in Major Depression Disease
Shadrina, M., Bondarenko, E. A., & Slominsky, P. A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00334 · Cited by 288
Konarski, J. Z., McIntyre, R. S., Kennedy, S. H., Rafi‐Tari, S., Soczynska, J. K., & Ketter, T. A. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00435.x · Cited by 299
??-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders
Hayashi, T., & Su, T.-P. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00001 · Cited by 294
Anisman, H. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0902 · Cited by 292
“, brain-derived neurotrophic factor [BDNF]).(7,8)”
Micheli, L., Ceccarelli, M., D’Andrea, G., & Tirone, F. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.002 · Cited by 288
Evaluation of Antidepressant-related Behavioral Responses in Mice Lacking the Serotonin Transporter
Holmes, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00374-3 · Cited by 286
“…inhibitory effects of antidepressants on the 5-HTT and an observable improvement in symptoms of depression, the mechanisms underlying the therapeutic effects of these drugs are likely to occur downstream of 5-HTT inhibition (Blier et al. 1990; Chaput et al. 1991; Duman 1998; Manji et al. 2001).”
Background
Metadata
- Authors
- Manji, H. K., Drevets, W. C., & Charney, D. S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Mental Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- Nature Medicine
- Published
- 2001-05
- Volume
- 7
- Issue
- 5
- Pages
- 541-547
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1509868652
- Cited by
- 1,182
- References
- 66
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 20 · 2023: 21 · 2022: 33 · 2021: 55 · 2020: 29 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 36 · 2015: 51 · 2014: 50 · 2013: 60 · 2012: 60
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, neurobiology of depression, neuroplasticity, cell survival, signaling pathways
- MeSH terms
- Antidepressive Agents, Cell Survival, Depressive Disorder, Glucocorticoids, Neuronal Plasticity, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.